Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-150
Closed -$11.3K 994
2026
Q1
$11.3K Hold
150
﹤0.01% 665
2025
Q4
$11.2K Hold
150
﹤0.01% 658
2025
Q3
$10.1K Hold
150
﹤0.01% 677
2025
Q2
$9.77K Hold
150
﹤0.01% 670
2025
Q1
$10.8K Hold
150
﹤0.01% 609
2024
Q4
$10.8K Hold
150
﹤0.01% 609
2024
Q3
$12.2K Hold
150
﹤0.01% 567
2024
Q2
$11.1K Hold
150
﹤0.01% 565
2024
Q1
$10.7K Hold
150
﹤0.01% 559
2023
Q4
$10.7K Hold
150
﹤0.01% 559
2023
Q3
$10.4K Hold
150
﹤0.01% 594
2023
Q2
$12.1K Hold
150
﹤0.01% 551
2023
Q1
$12.1K Hold
150
﹤0.01% 541
2022
Q4
$11.2K Buy
+150
New +$10.7K ﹤0.01% 564

Other funds holding HOLX

Armstrong Advisory Group's HOLX Position: Q2 2026 in Review

Armstrong Advisory Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 150 shares — an estimated $11.3K sold.

Armstrong Advisory Group first reported a position in HOLX in Q4 2022 and held it in 14 quarters. The position peaked at $12.2K in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Armstrong Advisory Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Armstrong Advisory Group sold 150 Hologic shares in Q2 2026, an estimated $11.3K.
  • Armstrong Advisory Group first reported a position in Hologic in Q4 2022 and held it in 14 quarters.
  • Armstrong Advisory Group's Hologic position peaked at $12.2K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.